Contract FA301616P0226
Hemoglobin Oxygen Therapeutics Llc · Department Of Defense · August 1, 2016
Hemoglobin Oxygen Therapeutics Llc was awarded a federal contract by Department Of Defense (Department Of The Air Force) on August 1, 2016 for $111,000 of work in pharmaceutical preparation manufacturing. Performance is in Souderton, PA. It was awarded under full and open competition. It uses firm fixed-price contract pricing.
Contract details
- PIID
- FA301616P0226
- Award type
- Purchase Order
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed Under Sap
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Chemical And Pharmaceutical Products Manufacturing Machinery
- Place of performance
- Souderton, PA
- First action
- August 1, 2016
Description
HEMOPURE BLOOD SUBSTITUTE 156 UNITS
Modification timeline
-
August 1, 2016Base award$110.8K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Cardinal Health, Inc. | Department Of Defense | January 1, 2026 | $51 |
| Cardinal Health, Inc. | Department Of Defense | January 1, 2026 | $91 |
| Cardinal Health, Inc. | Department Of Defense | January 1, 2026 | $32 |
| Cardinal Health, Inc. | Department Of Defense | January 1, 2026 | $1.1K |
| Cardinal Health, Inc. | Department Of Defense | January 1, 2026 | $22 |
| Cardinal Health, Inc. | Department Of Defense | December 31, 2025 | $23 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 53,729 | $99.76B |
| 2 | Pfizer Inc | 4,613 | $28.68B |
| 3 | Merck Sharp & Dohme Llc | 391 | $21.58B |
| 4 | Modernatx, Inc. | 3 | $8.20B |
| 5 | Sanofi Vaccines Us Inc. | 5,248 | $7.76B |
| 6 | Glaxosmithkline, Llc | 1,418 | $7.22B |
| 7 | Merck Sharp & Dohme Corp. | 349 | $5.33B |
| 8 | Pfizer Inc. | 3,842 | $4.83B |
| 9 | Eli Lilly And Company | 18 | $4.67B |
| 10 | Amerisourcebergen Drug Corp | 497 | $3.23B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract FA301616P0226?
Contract FA301616P0226 is a federal contract awarded to Hemoglobin Oxygen Therapeutics Llc by Department Of Defense on August 1, 2016 for $111,000 of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 0 times since the base award.
Who won contract FA301616P0226?
Hemoglobin Oxygen Therapeutics Llc won contract FA301616P0226 from Department Of Defense.
How much is contract FA301616P0226 worth?
Contract FA301616P0226 has obligated $111,000 to date.